Prajda N, Morris H P, Weber G
Cancer Res. 1976 Dec;36(12):4639-46.
The behavior of the rate-limiting enzyme of purine catabolism, xanthine oxidase (EC 1.2.3.2); was examined in normal liver, in 17 hepatomas of different growth rates, and in rapidly growing differentiating and regenerating liver. Xanthine oxidase activity was measured in the supernatant fluid prepared by centrifugation of 5% homogenates at 100,000 X g for 30 min. There was no uricase activity in the supernatant fluid. The affinity of xanthine oxidase to xanthine was similar in normal liver and in slow- and rapidly growing hepatomas (Km=6 to 8 muM), and theoptimum pH was 8.0; at pH 7.4, the activity was 80% of that at the pH optimum. A standard assay was worked out for the liver and hepatoma systems; the enzyme activity was linear during 60-min incubation and proportionate with amounts of protein added over a range of 0.5 to 3.0 mg. Xanthine oxidase specific activity was 9 times higher in small intestine than in liver. Activities in lung, spleen, kidney, heart, testes, and thymus were 67, 59, 21, 19, 8, and 8%, and in skeletal muscle, brain, and bone marrow activities were 5% of that of the liver. In regenerating liver, xanthine oxidase activity was not changed from that of the liver of sham-operated controls up to 96 hr after operation. The activity of the average differentiating liver cell was less than 5% of that of adult liver during the first week after birth. At postnatal ages of 18, 25, 30 and 40 days, the activity rose to 18, 46, 76, and 94%, respectively, of that of the adult liver. In starvation, hepatic xanthine oxidase activity per cell was preferentially depleted as compared to the decline in protein concentration. Upon refeeding, the enzymatic activity was restored more slowly than the protein content. Since xanthine oxidase activity was decreased in all examined hepatomas, including the slowest-growing, well-differentiated neoplasms, the altered activity of this enzyme appears to be.linked with neoplastic transformatiobosyl 1-pyrophosphate amidotransferase (EC 2.4.2.14), was increassed in the hepatomas, the reprogramming of gene expression results in an imbalance that favors the synthetic over the catabolic potential. This enzymatic imbalance should confer selective advantages to the cancer cells.
嘌呤分解代谢的限速酶黄嘌呤氧化酶(EC 1.2.3.2)的活性,在正常肝脏、17种不同生长速率的肝癌以及快速生长的分化和再生肝脏中进行了检测。黄嘌呤氧化酶活性是通过将5%的匀浆在100,000×g下离心30分钟制备的上清液中进行测定的。上清液中没有尿酸酶活性。黄嘌呤氧化酶对黄嘌呤的亲和力在正常肝脏以及生长缓慢和快速生长的肝癌中相似(Km = 6至8μM),最适pH为8.0;在pH 7.4时,活性为最适pH时活性的80%。针对肝脏和肝癌系统制定了标准测定方法;在60分钟的孵育过程中酶活性呈线性,并且在0.5至3.0毫克的蛋白质添加量范围内与添加的蛋白质量成比例。黄嘌呤氧化酶的比活性在小肠中比在肝脏中高9倍。肺、脾、肾、心脏、睾丸和胸腺中的活性分别为肝脏活性的67%、59%、21%、19%、8%和8%,而骨骼肌、脑和骨髓中的活性为肝脏活性的5%。在再生肝脏中,直到手术后96小时,黄嘌呤氧化酶活性与假手术对照组肝脏的活性没有变化。出生后第一周,平均分化的肝细胞活性小于成年肝脏活性的5%。在出生后18、25、30和40天时,活性分别升至成年肝脏活性的18%、46%、76%和94%。在饥饿状态下,与蛋白质浓度的下降相比,每个细胞的肝脏黄嘌呤氧化酶活性优先降低被耗尽。重新喂食后,酶活性的恢复比蛋白质含量恢复得更慢。由于在所有检测的肝癌中,包括生长最慢、分化良好的肿瘤中,黄嘌呤氧化酶活性都降低了,这种酶活性的改变似乎与肿瘤转化有关。1-焦磷酸核糖酰胺转移酶(EC 2.4.2.14)在肝癌中增加,基因表达的重新编程导致一种失衡,这种失衡有利于合成潜力而非分解代谢潜力。这种酶的失衡应该赋予癌细胞选择性优势。